NACLC
<ѻý class="page-description">North America Conference on Lung Cancerѻý>Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status
October 17, 2020
<ѻý class="section_title"> Latest Oncology/Hematology Meeting Coverageѻý>
-
ASTRO: American Society for Radiation Oncology
September 2024
-
ESMO: European Society for Medical Oncology
September 2024
-
ASCO: American Society of Clinical Oncology
May 2024
-
AACR: American Association for Cancer Research
April 2024